
### [MONDO:0016326](http://purl.obolibrary.org/obo/MONDO_0016326)
**Label:** lysosomal disease with hypertrophic cardiomyopathy

**Subclasses:** [MONDO:0016315](http://purl.obolibrary.org/obo/MONDO_0016315) (mucopolysaccharidosis type 2, severe form), [MONDO:0011759](http://purl.obolibrary.org/obo/MONDO_0011759) (Hurler-Scheie syndrome), [MONDO:0009562](http://purl.obolibrary.org/obo/MONDO_0009562) (beta-mannosidosis), [MONDO:0009254](http://purl.obolibrary.org/obo/MONDO_0009254) (fucosidosis), [MONDO:0017694](http://purl.obolibrary.org/obo/MONDO_0017694) (glycogen storage disease due to acid maltase deficiency, infantile onset), [MONDO:0018485](http://purl.obolibrary.org/obo/MONDO_0018485) (glycogen storage disease due to acid maltase deficiency, late-onset), [MONDO:0010674](http://purl.obolibrary.org/obo/MONDO_0010674) (mucopolysaccharidosis II), [MONDO:0011758](http://purl.obolibrary.org/obo/MONDO_0011758) (Hurler syndrome), [MONDO:0010526](http://purl.obolibrary.org/obo/MONDO_0010526) (Fabry disease), [MONDO:0009290](http://purl.obolibrary.org/obo/MONDO_0009290) (glycogen storage disease II), [MONDO:0016316](http://purl.obolibrary.org/obo/MONDO_0016316) (mucopolysaccharidosis type 2, attenuated form), 

**Corr. equiv. classes:** [Orphanet:365](http://www.orpha.net/ORDO/Orphanet_365), [Orphanet:580](http://www.orpha.net/ORDO/Orphanet_580), [Orphanet:308552](http://www.orpha.net/ORDO/Orphanet_308552), [OMIM:309900](http://purl.obolibrary.org/obo/OMIM_309900), [OMIM:301500](http://purl.obolibrary.org/obo/OMIM_301500), [OMIM:248510](http://purl.obolibrary.org/obo/OMIM_248510), [OMIM:232300](http://purl.obolibrary.org/obo/OMIM_232300), [OMIM:230000](http://purl.obolibrary.org/obo/OMIM_230000), [Orphanet:420429](http://www.orpha.net/ORDO/Orphanet_420429), [Orphanet:217085](http://www.orpha.net/ORDO/Orphanet_217085), [Orphanet:93473](http://www.orpha.net/ORDO/Orphanet_93473), [Orphanet:118](http://www.orpha.net/ORDO/Orphanet_118), [Orphanet:349](http://www.orpha.net/ORDO/Orphanet_349), [OMIM:607015](http://purl.obolibrary.org/obo/OMIM_607015), [OMIM:607014](http://purl.obolibrary.org/obo/OMIM_607014), [Orphanet:324](http://www.orpha.net/ORDO/Orphanet_324), [Orphanet:217093](http://www.orpha.net/ORDO/Orphanet_217093), [Orphanet:93476](http://www.orpha.net/ORDO/Orphanet_93476), 

**Class expressions from DL-Learner:**

- [HP:0002683](http://purl.obolibrary.org/obo/HP_0002683) (Abnormality of the calvaria) and [HP:0003541](http://purl.obolibrary.org/obo/HP_0003541) (Urinary glycosaminoglycan excretion) and [HP:0012374](http://purl.obolibrary.org/obo/HP_0012374) (Abnormality of the globe) 47.60%
- [HP:0002683](http://purl.obolibrary.org/obo/HP_0002683) (Abnormality of the calvaria) and [HP:0003541](http://purl.obolibrary.org/obo/HP_0003541) (Urinary glycosaminoglycan excretion) and [HP:0012372](http://purl.obolibrary.org/obo/HP_0012372) (Abnormal eye morphology) 47.60%
- [HP:0001249](http://purl.obolibrary.org/obo/HP_0001249) (Intellectual disability) and [HP:0002683](http://purl.obolibrary.org/obo/HP_0002683) (Abnormality of the calvaria) and [HP:0003541](http://purl.obolibrary.org/obo/HP_0003541) (Urinary glycosaminoglycan excretion) 47.60%
- [HP:0000478](http://purl.obolibrary.org/obo/HP_0000478) (Abnormality of the eye) and [HP:0002683](http://purl.obolibrary.org/obo/HP_0002683) (Abnormality of the calvaria) and [HP:0003541](http://purl.obolibrary.org/obo/HP_0003541) (Urinary glycosaminoglycan excretion) 47.60%
- [HP:0002683](http://purl.obolibrary.org/obo/HP_0002683) (Abnormality of the calvaria) and [HP:0003541](http://purl.obolibrary.org/obo/HP_0003541) (Urinary glycosaminoglycan excretion) and [HP:0012759](http://purl.obolibrary.org/obo/HP_0012759) (Neurodevelopmental abnormality) 46.16%
- [HP:0001507](http://purl.obolibrary.org/obo/HP_0001507) (Growth abnormality) and [HP:0002683](http://purl.obolibrary.org/obo/HP_0002683) (Abnormality of the calvaria) and [HP:0003541](http://purl.obolibrary.org/obo/HP_0003541) (Urinary glycosaminoglycan excretion) 46.16%
- [HP:0001249](http://purl.obolibrary.org/obo/HP_0001249) (Intellectual disability) and [HP:0003541](http://purl.obolibrary.org/obo/HP_0003541) (Urinary glycosaminoglycan excretion) and [HP:0012374](http://purl.obolibrary.org/obo/HP_0012374) (Abnormality of the globe) 46.16%
- [HP:0001249](http://purl.obolibrary.org/obo/HP_0001249) (Intellectual disability) and [HP:0003541](http://purl.obolibrary.org/obo/HP_0003541) (Urinary glycosaminoglycan excretion) and [HP:0012372](http://purl.obolibrary.org/obo/HP_0012372) (Abnormal eye morphology) 46.16%
- [HP:0001249](http://purl.obolibrary.org/obo/HP_0001249) (Intellectual disability) and [HP:0001507](http://purl.obolibrary.org/obo/HP_0001507) (Growth abnormality) and [HP:0003541](http://purl.obolibrary.org/obo/HP_0003541) (Urinary glycosaminoglycan excretion) 46.16%
- [HP:0000478](http://purl.obolibrary.org/obo/HP_0000478) (Abnormality of the eye) and [HP:0001249](http://purl.obolibrary.org/obo/HP_0001249) (Intellectual disability) and [HP:0003541](http://purl.obolibrary.org/obo/HP_0003541) (Urinary glycosaminoglycan excretion) 46.16%
- [HP:0002683](http://purl.obolibrary.org/obo/HP_0002683) (Abnormality of the calvaria) and [HP:0003541](http://purl.obolibrary.org/obo/HP_0003541) (Urinary glycosaminoglycan excretion) and [HP:0012638](http://purl.obolibrary.org/obo/HP_0012638) (Abnormality of nervous system physiology) 44.90%
- [HP:0002683](http://purl.obolibrary.org/obo/HP_0002683) (Abnormality of the calvaria) and [HP:0003541](http://purl.obolibrary.org/obo/HP_0003541) (Urinary glycosaminoglycan excretion) 43.77%
- [HP:0000707](http://purl.obolibrary.org/obo/HP_0000707) (Abnormality of the nervous system) and [HP:0002683](http://purl.obolibrary.org/obo/HP_0002683) (Abnormality of the calvaria) and [HP:0003541](http://purl.obolibrary.org/obo/HP_0003541) (Urinary glycosaminoglycan excretion) 43.77%
- [HP:0002683](http://purl.obolibrary.org/obo/HP_0002683) (Abnormality of the calvaria) and [HP:0004371](http://purl.obolibrary.org/obo/HP_0004371) (Abnormality of glycosaminoglycan metabolism) 42.76%
- [HP:0001249](http://purl.obolibrary.org/obo/HP_0001249) (Intellectual disability) and [HP:0003541](http://purl.obolibrary.org/obo/HP_0003541) (Urinary glycosaminoglycan excretion) 42.76%


